Today, we’re announcing $2M in funding for a new pediatric brain cancer clinical trial. Dr. Mohamed Abdelbaki’s team is testing a new type of cancer immunotherapy in children with recurrent brain tumors, with funding from a CureSearch Catapult Award. 

CureSearch for Children’s Cancer announced today that it will award $2 million in funding to support a Phase I clinical trial in 24 children and young adults with recurrent brain tumors, a diagnosis with a devastating prognosis. More than 15,000 children are diagnosed with cancer each year in the U.S. and are in desperate need of tailored treatment options.